{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:44:45Z","timestamp":1784634285201,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11655-019-3221-5","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T08:03:41Z","timestamp":1564992221000},"page":"696-703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Benefits and Safety of Tripterygium Glycosides and Total Glucosides of Paeony for Rheumatoid Arthritis: An Overview of Systematic Reviews"],"prefix":"10.1007","volume":"25","author":[{"given":"Jing","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-jiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-wen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"3221_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010;376:1094\u20131108.","journal-title":"Lancet"},{"key":"3221_CR2","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014;73:1316\u20131322.","journal-title":"Ann Rheum Dis"},{"key":"3221_CR3","first-page":"1","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol 2016;68:1\u201326.","journal-title":"Arthritis Rheumatol"},{"key":"3221_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.biopha.2006.09.008","volume":"60","author":"JH Yen","year":"2006","unstructured":"Yen JH. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying antirheumatic drugs? Biomed Pharmacother 2006;60:688\u2013692.","journal-title":"Biomed Pharmacother"},{"key":"3221_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/ard.2008.101378","volume":"69","author":"JR Curtis","year":"2010","unstructured":"Curtis JR, Beukelman T, Onofrei A, Cassell S, Greenberg JD, Kavanaugh A, et al. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and\/or leflunomide. Ann Rheum Dis 2010;69:43\u201347.","journal-title":"Ann Rheum Dis"},{"key":"3221_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/annrheumdis-2013-204807","volume":"74","author":"QW Lv","year":"2015","unstructured":"Lv QW, Zhang W, Shi Q, Zheng WJ, Li X, Chen H, et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis 2015;74:1078\u20131086.","journal-title":"Ann Rheum Dis"},{"key":"3221_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7326\/0003-4819-151-4-200908180-00005","volume":"151","author":"R Goldbach-Mansky","year":"2009","unstructured":"Goldbach-Mansky R, Wilson M, Fleischmann R, Olsen N, Silverfield J, Kempf P, et al. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Ann Intern Med 2009;151:229\u2013240.","journal-title":"Ann Intern Med"},{"key":"3221_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12906-016-1194-x","volume":"16","author":"HL Wang","year":"2016","unstructured":"Wang HL, Jiang Q, Feng XH, Zhang HD, Ge L, Luo CG, et al. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis. BMC Complement Altern Med 2016;16:215.","journal-title":"BMC Complement Altern Med"},{"key":"3221_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctim.2017.07.010","volume":"34","author":"J Luo","year":"2017","unstructured":"Luo J, Jin DE, Yang GY, Zhang YZ, Wang JM, Kong WP, et al. Total glucosides of paeony for rheumatoid arthritis: a systematic review of randomized controlled trials. Complement Therap Med 2017;34:46\u201356.","journal-title":"Complement Therap Med"},{"key":"3221_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.phymed.2006.01.010","volume":"13","author":"PH Canter","year":"2006","unstructured":"Canter PH, Lee HS, Ernst E. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis. Phytomedicine 2006;13:371\u2013377.","journal-title":"Phytomedicine"},{"key":"3221_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jclinepi.2017.10.002","volume":"93","author":"KI Bougioukas","year":"2018","unstructured":"Bougioukas KI, Liakos A, Tsapas A, Ntzani E, Haidich AB. Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms. J Clin Epidemiol 2018;93:9\u201324.","journal-title":"J Clin Epidemiol"},{"key":"3221_CR12","unstructured":"Luo J, Song WJ, Xu Y, Chen GY, Hu Q, Tao QW. Oral Chinese proprietary medicine for rheumatoid arthritis: an overview of systematic reviews. Accessed September 15, 2017. Available from: \n                    https:\/\/www.crd.york.ac.uk\/prospero\/#recordDetails"},{"key":"3221_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10.","journal-title":"BMC Med Res Methodol"},{"key":"3221_CR14","doi-asserted-by":"publisher","first-page":"e1350","DOI":"10.1371\/journal.pone.0001350","volume":"2","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Bouter LM, Peterson J, Boers M, Andersson N, Ortiz Z, et al. External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One 2007;2:e1350.","journal-title":"PLoS One"},{"key":"3221_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1590\/S1678-77572011000500002","volume":"19","author":"P Sequeira-Byron","year":"2011","unstructured":"Sequeira-Byron P, Fedorowicz Z, Jagannath VA, Sharif MO. An AMSTAR assessment of the methodological quality of systematic reviews of oral healthcare interventions published in the Journal of Applied Oral Science (JAOS). J Appl Oral Sci 2011;19:440\u2013447.","journal-title":"J Appl Oral Sci"},{"key":"3221_CR16","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH). Interventions Directed to Consumers. Available from: \n                    https:\/\/www.cadth.ca\/interventions-directed-consumers\n                    \n                  . Accessed October 22, 2017."},{"key":"3221_CR17","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"GRADE Working Group","year":"2004","unstructured":"GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.","journal-title":"BMJ"},{"key":"3221_CR18","first-page":"3731","volume":"21","author":"X Zhong","year":"2010","unstructured":"Zhong X, Su N, Zhou SH, Yang NP, Xie ZG. Meta-analysis of the efficacy and safety of total glucosides of paeony combined with immunosuppressant in the treatment of rheumatoid arthritis. China Pharm (Chin) 2010;21:3731\u20133734.","journal-title":"China Pharm (Chin)"},{"key":"3221_CR19","first-page":"1115","volume":"27","author":"HC Li","year":"2012","unstructured":"Li HC, Wen CP, Wang MJ, Xie ZJ, Han CW. Meta-analysis of total glucosides paeony combined with methorexate in treating rheumatoid arthritis. China J Tradit Chin Med Pharm (Chin) 2012;27:1115\u20131119.","journal-title":"China J Tradit Chin Med Pharm (Chin)"},{"key":"3221_CR20","first-page":"83","volume":"34","author":"XJ Guo","year":"2013","unstructured":"Guo XJ, Li S, Huang YS. Efficacy and safety of total glucosides of peony for rheumatoid arthritis: a meta-analysis. J Jinggangshan Univ (Natural Sci, Chin) 2013;34:83\u201387.","journal-title":"J Jinggangshan Univ (Natural Sci, Chin)"},{"key":"3221_CR21","first-page":"410793","volume":"2013","author":"Y Liu","year":"2013","unstructured":"Liu Y, Tu S, Gao W, Wang Y, Liu P, Hu Y, et al. Extracts of Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: a systemic review and meta-analysis of randomised controlled trials. Evid Based Complement Alternat Med 2013;2013:410793.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3221_CR22","first-page":"9852793","volume":"2016","author":"Z Feng","year":"2016","unstructured":"Feng Z, Xu J, He G, Cao M, Duan L, Chen L, et al. The efficacy and safety of the combination of total glucosides of peony and leflunomide for the treatment of rheumatoid arthritis: a systemic review and meta-analysis. Evid Based Complement Alternat Med 2016;2016:9852793.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3221_CR23","first-page":"32","volume":"22","author":"X Xu","year":"2016","unstructured":"Xu X, Li QJ, Xia S, Wang MM, Ji W. Tripterygium glycosides for treating late-onset rheumatoid arthritis: a systematic review and meta-analysis. Altern Ther Health Med 2016;22:32\u201339.","journal-title":"Altern Ther Health Med"},{"key":"3221_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10067-017-3770-y","volume":"37","author":"ZT Feng","year":"2018","unstructured":"Feng ZT, Xu J, He GC, Cai SJ, Li J, Mei ZG A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of paeony combined with methotrexate in rheumatoid arthritis. Clin Rheumatol 2018;37:35\u201342.","journal-title":"Clin Rheumatol"},{"key":"3221_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2017.01.004","volume":"171","author":"X Wang","year":"2017","unstructured":"Wang X, Zu Y, Huang L, Yu J, Zhao H, Wen C, et al. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: a meta-analysis. Life Sci 2017;171:45\u201350.","journal-title":"Life Sci"},{"key":"3221_CR26","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/art.10411","volume":"46","author":"X Tao","year":"2002","unstructured":"Tao X, Younger J, Fan FZ, Wang B, Lipsky PE. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum 2002;46:1735\u20131743.","journal-title":"Arthritis Rheum"},{"key":"3221_CR27","doi-asserted-by":"publisher","first-page":"e20751","DOI":"10.1371\/journal.pone.0020751","volume":"6","author":"J Xiong","year":"2011","unstructured":"Xiong J, Wang H, Guo G, Wang S, He L, Chen H, et al. Male germ cell apoptosis and epigenetic histone modification induced by Tripterygium wilfordii Hook F. PLoS One 2011;6:e20751.","journal-title":"PLoS One"},{"key":"3221_CR28","doi-asserted-by":"publisher","first-page":"W7","DOI":"10.7326\/IsTranslatedFrom_M17-2977_1","volume":"167","author":"CW Cheng","year":"2017","unstructured":"Cheng CW, Wu TX, Shang HC, Li YP, Altman DG, Moher D, et al. CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration (traditional Chinese version). Ann Intern Med 2017;167:W7\u2013W20.","journal-title":"Ann Intern Med"},{"key":"3221_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","volume":"152","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726\u2013732.","journal-title":"Ann Intern Med"},{"key":"3221_CR30","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. (Accepted December 2, 2018)","journal-title":"BMJ"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-019-3221-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-019-3221-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-019-3221-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T23:28:22Z","timestamp":1596497302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-019-3221-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3221"],"URL":"https:\/\/doi.org\/10.1007\/s11655-019-3221-5","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"2 December 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None declared.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}